Valuation MaaT Pharma OTC Markets

Stocks

Real-time OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

06-26	MaaT Pharma Announces Plan to Request Re-Examination Following Negative CHMP Opinion for MaaT013 for the Treatment of Acute Graft-Versus-Host Disease	CI
06-26	MaaT Pharma to Seek Re-examination of Graft-versus-host Disease Therapy After Negative EU Medicines Agency Opinion	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	131.9	79.15	80.99	110.6	77.47	56.91	-	-
Change	-	-40.01%	2.32%	36.57%	-29.96%	-26.54%	-	-
Enterprise Value (EV) ¹	94.45	55.21	56.71	93.58	70.04	68.21	91.41	125.1
Change	-	-41.55%	2.73%	65.01%	-25.16%	-2.61%	34%	36.82%
P/E	-	-	-4.11x	-3.6x	-2.47x	-1.58x	-2.71x	-1.96x
PBR	-	-	-	10.1x	50.3x	-1.21x	-0.62x	-0.49x
PEG	-	-	-	-0.1x	0.2x	0.77x	0.1x	-0.1x
Capitalization / Revenue	136x	-	36.4x	34.4x	17.1x	5.84x	1.97x	1.22x
EV / Revenue	97.2x	-	25.5x	29.1x	15.5x	7x	3.17x	2.68x
EV / EBITDA	-11x	-	-2.97x	-3.5x	-2.5x	-2.44x	-3.12x	-4.89x
EV / EBIT	-	-	-2.84x	-3.29x	-2.36x	-2.24x	-7.8x	-7.37x
EV / FCF	-11.6x	-4.16x	-2.87x	-4.11x	-4.29x	-2.42x	-7.44x	-5.23x
FCF Yield	-8.65%	-24%	-34.8%	-24.4%	-23.3%	-41.4%	-13.4%	-19.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-	-	-1.7	-2.21	-1.95	-1.91	-1.112	-1.54
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	0.972	-	2.228	3.216	4.524	9.751	28.88	46.58
EBITDA ¹	-8.565	-	-19.07	-26.74	-27.99	-27.9	-29.31	-25.55
EBIT ¹	-	-	-19.94	-28.43	-29.73	-30.39	-11.72	-16.98
Net income ¹	-	-	-19.72	-28.9	-31.06	-31.69	-15.31	-8.091
Net Debt ¹	-37.5	-23.95	-24.28	-17.03	-7.427	11.3	34.5	68.16
Reference price ²	13.350	8.000	6.980	7.960	4.810	3.020	3.020	3.020
Nbr of stocks (in thousands)	9,884	9,894	11,603	13,895	16,105	18,844	-	-
Announcement Date	4/14/22	3/31/23	3/28/24	3/27/25	3/31/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	20.92x	7.37x	14.89x	1.39%	70.64B
ARGENX SE	37.73x	9.79x	30.06x	0.04%	66.11B
BIONTECH SE	-16.97x	7x	-8.8x	-.--%	27.98B
INSMED INCORPORATED	-76.73x	14.33x	-69.09x	-.--%	26.51B
WUXI BIOLOGICS (CAYMAN) INC.	30.49x	6.57x	17.18x	-.--%	26.44B
PHARMAESSENTIA CORPORATION	58.84x	21.89x	44.4x	0.26%	20.4B
GENMAB A/S	27.41x	5.14x	17.24x	-.--%	20.17B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1705.69x	40.09x	875.29x	-.--%	15.99B
EXELIXIS, INC.	17.09x	5.07x	11.84x	-.--%	13.69B
Average	200.50x	13.03x	103.67x	0.19%	31.99B
Weighted average by Cap.	109.52x	11.04x	58.45x	0.37%